September 2016
·
5 Reads
Journal of the American Society of Hypertension
This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
September 2016
·
5 Reads
Journal of the American Society of Hypertension
August 2016
·
20 Reads
Journal of the American Society of Hypertension
July 2016
·
8 Reads
·
1 Citation
Journal of the American Society of Hypertension
April 2016
·
12 Reads
·
2 Citations
Journal of the American Society of Hypertension
February 2016
·
8 Reads
Journal of the American Society of Hypertension
February 2016
·
3 Reads
Journal of the American Society of Hypertension
January 2016
·
33 Reads
Journal of the American Society of Hypertension
January 2016
·
16 Reads
Journal of the American Society of Hypertension
January 2016
·
15 Reads
Journal of the American Society of Hypertension
December 2015
·
2 Reads
Journal of the American Society of Hypertension
... Lacidipine acts by relaxing arteries, allowing blood to flow more freely, thereby decreasing blood pressure. It has low oral bioavailability (10%) due to first-pass metabolism [6]. A novel delivery system must be developed to improve bioavailability and deliver the drug in effective concentrations. ...
January 2013
... [4][5][6] Later, studies revealed and recommended to use the captopril over nifedipine due to the harmful and deadly effects of nifedipine including sudden fall in BP, brain and heart ischemia, and sudden death. [6][7][8][9] In several studies, the effect of 25 mg sublingual captopril on lowering BP has been compared with 10 mg of sublingual nifedipine, which had approximately the same effect on lowering BP; however, no significant side effects were observed with sublingual captopril. Nifedipine lowers BP faster than captopril, which causes side effects. ...
January 2009
... In addition to its preservative effect, NaCl plays two important roles in food. Kaplan (2000), points out that a person needs 2.4 g of sodium, that is, 6 g of NaCl per day. ...
Reference:
CHEESE WITH REDUCED SALT CONTENT
May 2000
American Journal of Clinical Nutrition
... The ACC/AHA [45] was the only guideline body to recommend a target SBP less than 130 mmHg for older patients, and individualized decisions regarding BP-lowering intensity if high burden of comorbidity and limited life expectancy. The Malaysian [48] CPG recommend this goal for fit [65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80] year-olds, otherwise they suggested a SBP less than 140 mmHg or less than 150 mmHg for patients 80 years or older. NICE [42] also divides its recommendations for patients less than 80 and at least 80 years old, recommending BP less than 140/90 mmHg and BP less than 150/90 mmHg, respectively. ...
July 2016
Journal of the American Society of Hypertension
... Situating this act of consuming unstandardized foods and water, Kaplan (2016) states that: ...
April 2016
Journal of the American Society of Hypertension
... While genetic testing quickly deals with the first issue, and CT scanning the third, it is the differentiation of unilateral from (non-FH-I) bilateral PA that poses the greatest challenge. It has been argued that, given the effort and expense involved in the diagnostic workup for PA (and especially subtype differentiation), consideration should be given to using spironolactone or eplerenone as first line agents in every patient thought to have PA (255,257) and even in all new hypertensives (160,162). However, this approach would mean that the 30% or so patients with PA who have unilateral forms would be denied the opportunity to undergo surgery and thereby experience a surgical cure and, in terms of both cardiovascular outcomes (81,504) and quality of life (9), superior benefits to those observed with medical therapy in bilateral PA. ...
October 2004
Journal of Hypertension
... Algunos subtipos de asma u otras enfermedades relacionadas, cuando se asocian con el asma pueden favorecer la aparición de un ADC. Entre éstos se encuentra el inducido por intolerancia a los AINE, el de riesgo vital, el del anciano, el corticorresistente, la aspergilosis broncopulmonar alérgica (ABPA), el síndrome de Churg-Strauss (SCS), el hipertiroidismo y el reflujo gastroesofágico [253][254][255] (evidencias B y C). El abordaje diagnóstico del ADC de forma protocolizada puede ayudar a determinar dichos subtipos 256,257 . ...
Reference:
Guía Española para el Manejo del Asma
March 2000
The American Journal of the Medical Sciences
... Although various risk factors for the development of CAN have been identified, its pathogenesis is incompletely defined (for an excellent article on this subject, please refer to [13]). Both alloantigen-dependent and alloantigen-independent mechanisms are thought to play a part in the pathogenesis of the condition [12][13][14][15][16][17][18][19] (Table 1). Pilmore and Dittmer's study, reported in 2002, showed that chronic CyA toxicity (defined as extensive arteriolar hyalinosis and obliteration), though frequently colocalizing with glomerular and interstitial fibrotic changes, was a separate entity, and although renal function deteriorated progressively in patients with or without chronic vascular changes, those patients with chronic vasculopathy due to CNIs responded almost uniformly favorably to reduction in calcineurin inhibitor exposure [22]. ...
July 2000
The American Journal of the Medical Sciences
... This understanding formed the basis for the clinical application of anti-estrogens, which compete with estrogen for binding to the estrogen receptor (ER) and block hormone-responsive breast cancers [Jordan et al., 1978]. Anti-estrogens can also decrease breast cancer incidence in certain highrisk populations [Osborne, 1999;Jordan, 2000;Yardley, 2000]. ...
October 2000
The American Journal of the Medical Sciences
... Outcomes research provides evidence of health care practices and interventions in terms of, for example, the ability to function, or the level of pain, the costs or the risks involved in undergoing a surgical procedure [18]. Outcomes research ties patient experience to the type of treatment they receive. ...
April 2000
The American Journal of the Medical Sciences